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Rheumatoid arthritis (RA) is an inflammatory autoimmune disease affecting about 0.24 % of the world
population. Protein  arginine  deiminase  type  4  ( PAD4 ) is believed to be responsible for the
occurrence of RA by catalyzing citrullination of proteins. The citrullinated proteins act as autoantigens
by stimulating an immune response. Citrullinated α-enolase has been identified as one of the
autoantigens for RA. Hence, α-enolase serves as a suitable template for design  of potential peptide
inhibitors against PAD4 . The binding affinity of α-enolase-derived peptides  and PAD4  was virtually
determined using PatchDock and HADDOCK docking programs. Synthesis of the designed peptides
was performed using a solid phase peptide  synthesis method. The inhibitory potential of each 
peptide  was determined experimentally by PAD4  inhibition assay and IC  measurement. PAD4
assay data show that the N-P2 peptide  is the most favourable substrate among all peptides . Further
modification of N-P2 by changing the Arg residue to canavanine [P2 (Cav)] rendered it an inhibitor
against PAD4  by reducing the PAD4  activity to 35 % with IC  1.39 mM. We conclude that P2 (Cav) is a
potential inhibitor  against PAD4  and can serve as a starting point for the development of even more
potent inhibitors. © 2021 Elsevier Ltd
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